MedTrace Logo

Decision Aid for Dementia Therapies

NCT06638632 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-09-16

No results posted yet for this study

Summary

The purpose of this study is to develop a decision aid to support patients and families making decisions about medications for dementia.

Conditions

Interventions

BEHAVIORAL

Decision aid

Patients with dementia and care partners will receive an iteration of the decision aid and provide feedback.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Dan Matlock, MD, MPH · University of Colorado, Denver

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-30
Primary Completion
2026-01-31
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06638632 on ClinicalTrials.gov